Pine Pharmaceuticals recalls

Pine Pharmaceuticals has 24 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 25 Oct 2023. The most frequent reason is sterility.

Total recalls24since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 25 Oct 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 22 92%Class III 2 8%

By year

All pine pharmaceuticals recalls, newest first

24 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITropi-Phen (Tropicamide 1% phenylephrine HCl 2.5%) recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IIFoscarnet Sodium 2.4mg/ solution recalled by Pine PharmaceuticalsPine PharmaceuticalsSterilityNationwide
DrugCLASS IIEndophth Kit (Vancomycin 1mg/ - Ceftazidime 2.25mg recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IIBevacizumab 1.25 MG/ Solution for Injection syringes recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IITropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IIVancomycin 1 MG/ Solution for Intraocular Injection Single Dose Vial recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IICalcium Gluconate 2.5% solution for inhalation pre-filled syringes recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IILidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IICalcium Gluconate Ophthalmic Irrigation Solution recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IITPC Drops (tropicamide 1%- phenylephrine recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IIMoxifloxacin in Balanced Salt Solution, Solution recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IILidocaine HCl 4% ophthalmic solution single-use dropper recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IICalcium chloride Solution for Intravenous Injection, 20 mg/mL recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IIMoxifloxacin in Balanced Salt Solution 400 mcg/ (100 mcg/ syringes recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IICefuroxime 4mg / (10 mg/mL) syringe recalled by Pine PharmaceuticalsPine PharmaceuticalsSterilityNationwide
DrugCLASS IILidocaine-phenylephrine 1%-1.5% Single Dose Vial recalledPine PharmaceuticalsSterilityNationwide
DrugCLASS IIIBevacizumab 2.5 mg/, Solution for Injection recalledPine PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IIEpi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution recalledPine PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIBupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v recalledPine PharmaceuticalsSterility4 states
DrugCLASS IIIBrilliant Blue G for Intraocular Injection vial 0.25 mg/mL recalledPine PharmaceuticalsLabeling ErrorsNY
DrugCLASS IIBevacizumab 1.25 mg/ filled to in 5/16" Syringe recalledPine PharmaceuticalsParticulate MatterNationwide
DrugCLASS IIBevacizumab 2.5 mg/ in 5/16" Syringe recalled by Pine PharmaceuticalsPine PharmaceuticalsParticulate MatterNationwide
DrugCLASS IIBevacizumab 2 mg/ in 5/16" Syringe for intravitreal recalledPine PharmaceuticalsParticulate MatterNationwide
DrugCLASS IIBevacizumab 1.25 mg/ in 5/16" Syringe recalled by Pine PharmaceuticalsPine PharmaceuticalsParticulate MatterNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.